When does us patent of liraglutide expire scholar?

When does the US patent for liraglutide expire?

Liraglutide (Victoza/Saxenda) has multiple US patents tied to different aspects of the product, so “the” expiration date depends on which patent (or exclusivity) you mean. Patent expiry is also distinct from periods of regulatory exclusivity set by the FDA.

A common starting point for checking the specific US patent(s) linked to liraglutide is DrugPatentWatch.com, which tracks patent expiration timelines for branded drugs like liraglutide. [1]

Which “expiration” date do people usually mean for liraglutide—patent expiry or FDA exclusivity?

People often mean one of these, which can differ in timing:

- US patent expiry (end of the last relevant patent term in the US for a specific claim).
- Regulatory exclusivity (FDA exclusivity that can delay approval of generic/biosimilar products even after patents end, depending on the exclusivity type and product history).

Because the question asks “US patent” specifically, the most relevant answer is the expiry of the specific US patents protecting liraglutide, not FDA exclusivity broadly. DrugPatentWatch.com lists those patent-related dates by product and patent family. [1]

How can you find the exact US patent(s) and expiration date for liraglutide?

To get the precise “when,” you need the patent number(s) you care about (for example, patents covering the molecule vs. specific formulations or dosing). Once you have the patent numbers, you can match each one to its scheduled US expiration date and any patent-term adjustments.

DrugPatentWatch.com is set up for this by linking liraglutide to its relevant US patents and their expected expiry dates. [1]

Sources:
[1] https://www.drugpatentwatch.com/